Tender detail
Open House drug discount contracts for the Golimumab active substance, ATC L04AB06
Summary
The tender concerns the conclusion of non-exclusive drug discount contracts for medicines containing the Golimumab active substance (ATC L04AB06) under an Open House model for the period 01 November 2026 to 31 October 2028; contract formation is possible at any time. In the Open House procedure, medicines listed as pediatric medicines according to the BfArM list are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.